|
|
||||||||



1 Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Brisbane, QLD 4029, Australia
2 Clinical Medical Virology Research Centre, University of Queensland, St Lucia, QLD 4067, Australia
Correspondence
Eric Gowans (at Macfarlane Burnet Institute)
gowans{at}burnet.edu.au
A self-modulating mechanism by the hepatitis C virus (HCV) core protein has been suggested to influence the level of HCV replication, but current data on this subject are contradictory. We examined the effect of wild-type and mutated core protein on HCV IRES- and cap-dependent translation. The wild-type core protein was shown to inhibit both IRES- and cap-dependent translation in an in vitro system. This effect was duplicated in a dose-dependent manner with a synthetic peptide representing amino acids 120 of the HCV core protein. This peptide was able to bind to the HCV IRES as shown by a mobility shift assay. In contrast, a peptide derived from the hepatitis B virus (HBV) core protein that contained a similar proportion of basic residues was unable to inhibit translation or bind the HCV IRES. A recombinant vacciniaHCV core virus was used to examine the effect of the HCV core protein on HCV IRES-dependent translation in cells and this was compared with the effects of an HBV core-recombinant vaccinia virus. In CV-1 and HuH7 cells, the HCV core protein inhibited translation directed by the IRES elements of HCV, encephalomyocarditis virus and classical swine fever virus as well as cap-dependent translation, whereas in HepG2 cells, only HCV IRES-dependent translation was affected. Thus, the ability of the HCV core protein to selectively inhibit HCV IRES-dependent translation is cell-specific. N-terminal truncated (aa 120) HCV core protein that was expressed from a novel recombinant vaccinia virus in cells abrogated the inhibitory phenotype of the core protein in vivo, consistent with the above in vitro data.
Present address: Macfarlane Burnet Institute for Medical Research and Public Health, Cnr Punt & Commercial Roads, Prahran, VIC 3181, Australia.
Present address: Sinsheimer Laboratories, University of California, Santa Cruz, CA 95064, USA.
This article has been cited by other articles:
![]() |
L. Jaffrelo, S. Chabas, S. Reigadas, A. Pflieger, C. Wychowski, J. Rumi, M. Ventura, J.-J. Toulme, and C. Staedel A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors Nucleic Acids Res., September 1, 2008; 36(15): e95 - e95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, M. Dimitrova, T. F. Baumert, and C. Schuster The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression Nucleic Acids Res., May 1, 2008; 36(9): 3054 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. MacCallum, S. C. Jack, P. A. Egan, B. T. McDermott, R. M. Elliott, and S.-W. Chan Cap-dependent and hepatitis C virus internal ribosome entry site-mediated translation are modulated by phosphorylation of eIF2{alpha} under oxidative stress. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3251 - 3262. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lin, S. S. Kim, E. Yeung, Y. Kamegaya, J. T. Blackard, K. A. Kim, M. J. Holtzman, and R. T. Chung Hepatitis C Virus Core Protein Blocks Interferon Signaling by Interaction with the STAT1 SH2 Domain. J. Virol., September 1, 2006; 80(18): 9226 - 9235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boni, J.-P. Lavergne, S. Boulant, and A. Cahour Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA J. Biol. Chem., May 6, 2005; 280(18): 17737 - 17748. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Kalliampakou, M. Kalamvoki, and P. Mavromara Hepatitis C virus (HCV) NS5A protein downregulates HCV IRES-dependent translation J. Gen. Virol., April 1, 2005; 86(4): 1015 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, W. B. Lott, J. Martyn, G. Haqshenas, and E. J. Gowans Differential Effects on the Hepatitis C Virus (HCV) Internal Ribosome Entry Site by Vitamin B12 and the HCV Core Protein J. Virol., November 1, 2004; 78(21): 12075 - 12081. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Majeau, V. Gagne, A. Boivin, M. Bolduc, J.-A. Majeau, D. Ouellet, and D. Leclerc The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation J. Gen. Virol., April 1, 2004; 85(4): 971 - 981. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |